Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

BACKGROUND: Few data are available on compliance and safety of adjuvant chemotherapy when indicated in elderly breast cancer patients; CMF (cyclophosphamide, methotrexate, fluorouracil) can be reasonably considered the most widely accepted standard of treatment. METHODS: We retrospectively reviewed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: De Maio, Ermelinda, Gravina, Adriano, Pacilio, Carmen, Amabile, Gerardo, Labonia, Vincenzo, Landi, Gabriella, Nuzzo, Francesco, Rossi, Emanuela, D'Aiuto, Giuseppe, Capasso, Immacolata, Rinaldo, Massimo, Morrica, Brunello, Elmo, Massimo, Di Maio, Massimo, Perrone, Francesco, de Matteis, Andrea
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2005
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1079800/
https://ncbi.nlm.nih.gov/pubmed/15790416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-5-30
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars